Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome.
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Polyunsaturated fatty acids in multiple sclerosis therapy.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Solodyn
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Condition-specific preference-based measures: benefit or burden?
Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
IgM antibody identifies good candidates for natalizumab
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Clinical analysis of the etiology of optic neuritis in patients at different ages in china.

Pages